|Articles|August 4, 2020

Phlexglobal Launches End-to-End TMF Solution

Author(s)Applied Clinical Trials Editorial Staff

Phlexglobal, a technology and services provider for the life sciences industry, announced PhlexTMF+, a one-stop, full-service solution that encompasses the software and services required for effective TMF management and ongoing inspection-readiness and compliance throughout the TMF lifecycle.

For more information, click here.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Phlexglobal Launches End-to-End TMF Solution

Related Content

Beyond Patient Centricity: What Rare Disease Research Gets Right

The Unquantified Value of RBQM: Reduced Rework, Data Integrity, and Inspection Readiness

ACT Brief: Time Savings as RBQM Value Driver, FDA Tightens Foreign Trial Oversight, and Trusted Research Environments Versus Flat Files

FDA Reaffirms GCP Standards Amid Growing Concerns Over Foreign Clinical Trial Data

Why Time Savings Is the Largest Driver of RBQM's Financial Value

Trending on Applied Clinical Trials Online

Beyond Patient Centricity: What Rare Disease Research Gets Right

AI Moves Patient Recruitment from Trial Bottleneck to Competitive Edge: A 2026 Perspective

Fortrea to Acquire Worldwide Clinical Trials' Early Phase Services Division in $45 Million Deal

FDA Reaffirms GCP Standards Amid Growing Concerns Over Foreign Clinical Trial Data

ACT Brief: Time Savings as RBQM Value Driver, FDA Tightens Foreign Trial Oversight, and Trusted Research Environments Versus Flat Files